3 results
Approved WMOCompleted
The primary objective of this study is to obtain clinical proof of principle that the addition of a PgP/BCRP inhibitor increases CNS concentrations of tyrosine kinase inhibitors by inhibition of drug efflux transporter function in the blood brain…
Approved WMOCompleted
To determine the pharmacokinetic properties of a new elacridar formulation
Approved WMOCompleted
The objective of this validation study is to determine whether the wearable sensors: HealthPatch, SensiumVitals and the bed-based contact-less EarlySense system are able to detect heart rate and respiratory rate in a clinical setting, with…